StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of SRNE stock opened at $0.01 on Friday. The stock’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.02. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.25.
About Sorrento Therapeutics
Read More
- Five stocks we like better than Sorrento Therapeutics
- Stock Sentiment Analysis: How it Works
- Brinker International’s Price Dip is an Appetizing Entry Point
- How to Invest in Blue Chip Stocks
- 3 Stocks That Could Beat the September Blues
- How to Evaluate a Stock Before Buying
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.